Announced Tue, 7 Jul · 12:42 IST
Routine compliance certificate for Q1 FY27 dematerialization
Compliance View source PDF
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.4%1-day move
₹421.35
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-4.4-3.4-4.5-5.1-5.4-8.0————
Up moveDown movePending
AI summary
SMS Pharmaceuticals submitted a quarterly compliance certificate under SEBI Regulation 74(5) for the period ending 30 June 2026. The certificate, issued by their Registrar Aarthi Consultants, confirms timely processing of share dematerialization requests, cancellation of physical share certificates, and updating depository records. This is a standard procedural filing required of all listed companies each quarter, with no business or financial impact.
Likely market impact
Routine regulatory filing with no material impact on operations or shareholders.